Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-25-000031

Options or other derivatives

  • Director acquired 19,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Zeiher Bernhardt G Director 2025-06-11 Grant or award · Stock Option (Right to Buy) +19,000 19,000 D
Loading xslF345X05/wk-form4_1749729970.xml…